控释羟可酮的临床应用进展  

Clinical application of controlled-release oxycodone

作　　者：孙海燕[1] 谢广茹[1] 

机构地区：[1]天津医科大学附属肿瘤医院中西医结合科,300060

出　　处：《实用疼痛学杂志》2006年第3期172-176,共5页Pain Clinic Journal

摘　　要：奥施康定是羟可酮的即释型与控释型的结合制剂,是阿片类长效止痛药。临床应用于中、重度癌痛与非癌痛,疗效相当于吗啡控释剂,等效止痛剂量约为吗啡的一半,不良反应较少。Controlled-release oxycodone is a long-acting opioid analgesic drug. This drug is effective for moderate to severe pain caused by cancer and nonmalignant diseases, which is comparable with controlled-release morphine. It is approximately twice as potent as controlled-release morphine, a milligram per milligram basis, but with lesser adverse effects.

关 键 词：羟可酮 疼痛 镇痛 

分 类 号：R96[医药卫生—药理学]